IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101. A total of 14 filers reported holding IMMUNE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $43,000 | – | 152,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Geduld E E | 40,000 | $134,000 | 0.10% |
| Bank Pictet & Cie (Europe) AG | 12,900 | $45,000 | 0.01% |
| Pine River Capital Management L.P. | 250,000 | $653,000 | 0.01% |
| Spark Investment Management LLC | 11,500 | $36,000 | 0.01% |
| UBS AG | 1 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 22,466 | $75,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 31,143 | $105,000 | 0.00% |
| MORGAN STANLEY | 10,203 | $35,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 1 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 881 | $3,000 | 0.00% |